TY - JOUR
T1 - European interdisciplinary guideline on invasive squamous cell carcinoma of the skin
T2 - Part 1. epidemiology, diagnostics and prevention
AU - the European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC)
AU - Stratigos, Alexander J.
AU - Garbe, Claus
AU - Dessinioti, Clio
AU - Lebbe, Celeste
AU - Bataille, Veronique
AU - Bastholt, Lars
AU - Dreno, Brigitte
AU - Fargnoli, Maria Concetta
AU - Forsea, Ana Maria
AU - Frenard, Cecille
AU - Harwood, Catherine
AU - Hauschild, Axel
AU - Hoeller, Christoph
AU - Kandolf-Sekulovic, Lidija
AU - Kaufmann, R.
AU - Kelleners-Smeets, Nicole WJ
AU - Malvehy, Josep
AU - del Marmol, Veronique
AU - Middleton, Mark R.
AU - Moreno-Ramirez, David
AU - Pellecani, Giovanni
AU - Peris, Ketty
AU - Saiag, Philippe
AU - van den Beuken-van Everdingen, Marieke H.J.
AU - Vieira, Ricardo
AU - Zalaudek, Iris
AU - Eggermont, Alexander M.M.
AU - Grob, Jean Jacques
N1 - Publisher Copyright:
© 2020 Elsevier Ltd
PY - 2020/3
Y1 - 2020/3
N2 - Invasive cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers in the white populations, accounting for 20% of all cutaneous malignancies. Factors implicated in cSCC etiopathogenesis include ultraviolet radiation exposure and chronic photoaging, age, male sex, immunosuppression, smoking and genetic factors. A collaboration of multidisciplinary experts from the European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organisation of Research and Treatment of Cancer (EORTC) was formed to update recommendations on cSCC classification, diagnosis, risk stratification, staging and prevention, based on current literature, staging systems and expert consensus. Common cSCCs are typically indolent tumors, and most have a good prognosis with 5-year cure rates of greater than 90%, and a low rate of metastases (<4%). Further risk stratification into low-risk or high-risk common primary cSCC is recommended based on proposed high-risk factors. Advanced cSCC is classified as locally advanced (lacSCC), and metastatic (mcSCC) including locoregional metastatic or distant metastatic cSCC. Current systems used for staging include the American Joint Committee on Cancer (AJCC) 8th edition, the Union for International Cancer Control (UICC) 8th edition, and Brigham and Women's Hospital (BWH) system. Physical examination for all cSCCs should include total body skin examination and clinical palpation of lymph nodes, especially of the draining basins. Radiologic imaging such as ultrasound of the regional lymph nodes, magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography–computed tomography (PET-CT) scans are recommended for staging of high-risk cSCC. Sentinel lymph node biopsy is currently not recommended. Nicotinamide, oral retinoids, and topical 5-FU have been used for the chemoprevention of subsequent cSCCs in high-risk patients but are not routinely recommended. Education about sun protection measures including reducing sun exposure, use of protective clothing, regular use of sunscreens and avoidance of artificial tanning, is recommended.
AB - Invasive cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers in the white populations, accounting for 20% of all cutaneous malignancies. Factors implicated in cSCC etiopathogenesis include ultraviolet radiation exposure and chronic photoaging, age, male sex, immunosuppression, smoking and genetic factors. A collaboration of multidisciplinary experts from the European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organisation of Research and Treatment of Cancer (EORTC) was formed to update recommendations on cSCC classification, diagnosis, risk stratification, staging and prevention, based on current literature, staging systems and expert consensus. Common cSCCs are typically indolent tumors, and most have a good prognosis with 5-year cure rates of greater than 90%, and a low rate of metastases (<4%). Further risk stratification into low-risk or high-risk common primary cSCC is recommended based on proposed high-risk factors. Advanced cSCC is classified as locally advanced (lacSCC), and metastatic (mcSCC) including locoregional metastatic or distant metastatic cSCC. Current systems used for staging include the American Joint Committee on Cancer (AJCC) 8th edition, the Union for International Cancer Control (UICC) 8th edition, and Brigham and Women's Hospital (BWH) system. Physical examination for all cSCCs should include total body skin examination and clinical palpation of lymph nodes, especially of the draining basins. Radiologic imaging such as ultrasound of the regional lymph nodes, magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography–computed tomography (PET-CT) scans are recommended for staging of high-risk cSCC. Sentinel lymph node biopsy is currently not recommended. Nicotinamide, oral retinoids, and topical 5-FU have been used for the chemoprevention of subsequent cSCCs in high-risk patients but are not routinely recommended. Education about sun protection measures including reducing sun exposure, use of protective clothing, regular use of sunscreens and avoidance of artificial tanning, is recommended.
KW - Diagnosis
KW - High-risk common primary cSCC
KW - Imaging
KW - Invasive cutaneous squamous cell carcinoma
KW - Locally advanced Cscc
KW - Low-risk
KW - Metastatic cSCC
KW - Prevention
KW - Prognosis
KW - Staging
UR - http://www.scopus.com/inward/record.url?scp=85080029310&partnerID=8YFLogxK
U2 - 10.1016/j.ejca.2020.01.007
DO - 10.1016/j.ejca.2020.01.007
M3 - Article
C2 - 32113941
AN - SCOPUS:85080029310
SN - 0959-8049
VL - 128
SP - 60
EP - 82
JO - European Journal of Cancer
JF - European Journal of Cancer
ER -